Microbiosci, the division of Creative Biogene, is dedicated to developing unique technologies that provide global scientists with high-quality products and satisfactory services to facilitate the investigation of microbial research. With a wide range of high-quality products and services in microbial genome editing, identification, sequencing, proteomics, and metabolomics, Microbiosci is capable to deliver medicine microbiology solutions to clinical, pharmaceutical and veterinary by infection detection, prevention and novel pharmaceutical protein production. Recently, Microbiosci announced the release of its yeast cell bank characterizationservice to test the identity, purity, and genetic stability of microbial cell banks.

With rapid advances in genomics, transcriptomics, proteomics, and metabolomics, the industrial application of microbial systems offers great potential to heal, feed, and fuel the world. Fermentation technologies use a wide range of microbial hosts to produce a variety of biopharmaceuticals including interferons, hormones, cytokines, blood products, enzymes and vaccines. As a premier research support organization, Creative Biogene has extensive experience in the characterization of microbial cell banks for pharmaceutical products, pesticides, veterinary drugs and industrial enzymes.

Creative Biogene has developed microbial cell banking systems that allow the use of the same, unchanging starting material throughout the manufacturing process. The creation of cell banks reduces the cost of continuous culture and allows the storage of cell material in an unchanged and intact form, making it a good alternative to continuous culture. From stable system selection, cell bank system construction to recombinant protein production, these stages refer to the ICH guidelines applicable to each production stage. The most important guidelines for establishing cell banks are collected in ICH Q5B and ICH Q5D.

Furthermore, E. coli bacterial cells are the most commonly used production cells. Creative Biogene's laboratory provides proven microbial cell line characterization methods, and cell bank characterization services according to different needs, including master cell bank, working cell bank and end-of-production cell bank. Reliable, fast, and accurate results will be provided to assist customers in assessing the quality of their cell banks.

“We offer a comprehensive suite of microbial cell bank characterization services to support research, process development, and preclinical studies.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “We can respond to customer requests for any process in the microbial cell bank characterization process. It is fully customizable and flexible to suit the way you run your projects.”

About Microbiosci

Microbiosci, as the division of Creative Biogene, is always dedicated to satisfying the needs of clients covering more than 50 countries and districts. As a leading custom service provider in delivering medicine microbiology solutions, Microbiosci has become a well-recognized industry leader with years of experience and professional scientists.